Zomedica
(NYSEMKT) ZOM
Zomedica Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$32.03M
Net Income (TTM)
$81.86M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ZOM News
ZOM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zomedica
Industry
Pharmaceuticals
Sector
Health CareEmployees
141
CEO
Larry C. Heaton, II
Website
www.zomedica.comHeadquarters
Ann Arbor, MI 48108, US
ZOM Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-66%
Return on Capital
-72%
Return on Assets
-64%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$21.68M
Operating Income
$84.35M
EBITDA
$84.35M
Operating Cash Flow
$17.65M
Capital Expenditure
$0.00
Free Cash Flow
$17.65M
Cash & ST Invst.
$53.26M
Total Debt
$717.00K
Zomedica Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.47M
+32.6%
Gross Profit
$7.17M
-4.7%
Gross Margin
68.47%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
144
N/A
Net Income
$4.53M
+37.0%
EBITDA
$7.53M
-40.4%
Quarterly Fundamentals
Net Cash
$52.54M
-24.4%
Accounts Receivable
$3.46M
+12.5%
Inventory
$5.54M
+9.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$717.00K
+37.1%
Return on Assets
-64.44%
N/A
Return on Invested Capital
-71.73%
N/A
Free Cash Flow
$899.00K
+86.4%
Operating Cash Flow
$899.00K
+80.1%